Alimera Sciences, Inc

(NASDAQ:ALIM)

Latest On Alimera Sciences, Inc (ALIM):

Date/Time Type Description Signal Details
2023-05-18 16:47 ESTNewsAlimera jumps 48% on deal with EyePoint for eye disorder therapy YutiqN/A
2023-05-15 20:39 ESTNewsAlimera Sciences GAAP EPS of -$0.71 misses by $0.19, revenue of $13.55M beats by $1.25MN/A
2023-04-03 17:08 ESTNewsAlimera expands distribution pact for eye drug implant Iluvien to Nordic regionN/A
2023-03-31 16:50 ESTNewsAlimera Sciences GAAP EPS of -$0.54 misses by $0.20, revenue of $14.03M misses by $0.59MN/A
2023-03-31 16:50 ESTNewsAlimera Sciences, Inc. (ALIM) Q4 2022 Earnings Call TranscriptN/A
2023-03-31 00:49 ESTNewsAlimera Sciences Q4 2022 Earnings PreviewN/A
2023-02-22 09:46 ESTNewsAlimera's partner files for approval of eye implant therapy Iluvien in SwitzerlandN/A
2022-11-14 22:09 ESTNewsAlimera Sciences GAAP EPS of -$0.75 misses by $0.35, revenue of $13.6M misses by $1.45MN/A
2022-11-14 22:08 ESTNewsAlimera Sciences, Inc. (ALIM) Q3 2022 Earnings Call TranscriptN/A
2022-11-12 00:39 ESTNewsAlimera Sciences Q3 2022 Earnings PreviewN/A
2022-10-06 22:49 ESTNewsAlimera confirmatory trial testing Iluvien in diabetic macular edema patients shows positive dataN/A
2022-09-20 12:06 ESTNewsAlimera's eye inflammation Iluvien injection granted reimbursement in IrelandN/A
2022-08-09 18:15 ESTNewsAlimera granted reimbursement in Portugal for eye inflammation Iluvien injectionN/A
2022-07-30 13:46 ESTNewsAlimera Sciences, Inc. (ALIM) CEO Rick Eiswirth on Q2 2022 Results - Earnings Call TranscriptN/A
2022-07-27 15:36 ESTNewsAlimera Sciences reports Q2 resultsN/A
2022-07-22 11:41 ESTNewsAlimera granted pricing, reimbursement in France for eye inflammation Iluvien injectionN/A
2022-07-08 14:52 ESTNewsAlimera gets Italian nod for its Iluvien injection to treat a form of eye inflammationN/A
2022-06-08 15:04 ESTNewsAlimera's partner Ocumension gets China regulator nod to start diabetic macular edema studyN/A
2022-05-10 01:38 ESTNewsAlimera Sciences GAAP EPS of -$0.85 misses by $0.16, revenue of $11.89M misses by $1.01MN/A
2022-05-10 01:38 ESTNewsAlimera Sciences, Inc (ALIM) CEO Richard Eiswirth on Q1 2022 Results - Earnings Call TranscriptN/A
2022-02-25 04:07 ESTNewsAlimera Sciences, Inc (ALIM) CEO Richard Eiswirth on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-24 08:20 ESTNewsAlimera Sciences GAAP EPS of -$0.59 misses by $0.17, revenue of $13.95M beats by $0.55MN/A
2022-02-23 12:21 ESTNewsAlimera's 3-year data for ILUVIEN shows benefit in diabetic macular edemaN/A
2022-02-23 12:21 ESTNewsAlimera Sciences Q4 2021 Earnings PreviewN/A
2021-10-28 16:20 ESTNewsAlimera Sciences EPS misses by $0.07, misses on revenueN/A
2021-10-28 16:20 ESTNewsAlimera Sciences, Inc. (ALIM) CEO Richard Eiswirth on Q3 2021 Results - Earnings Call TranscriptN/A
2021-10-13 16:44 ESTNewsAlimera posts real world data to show benefits of ILUVIEN in Diabetic Macular EdemaN/A
2021-10-12 20:00 ESTNewsWarning: ALIM is at high risk of performing badlyN/A
2021-10-07 04:05 ESTNewsALIM is at high risk of performing badlyN/A
2021-09-27 12:15 ESTNewsWarning: ALIM has been downgraded to Very BearishN/A
2021-09-21 11:22 ESTNewsWarning: ALIM has been downgraded to Very Bearish.N/A
2021-08-14 04:56 ESTNewsAlimera Sciences' (ALIM) CEO Rick Eiswirth on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-13 08:26 ESTNewsAlimera Sciences Q2 2021 Earnings PreviewN/A
2021-08-13 08:25 ESTNewsAlimera Sciences EPS misses by $0.03, beats on revenueN/A
2021-05-01 23:41 ESTNewsAlimera Sciences Inc. (ALIM) CEO Rick Eiswirth on Q1 2021 Results - Earnings Call TranscriptN/A
2021-04-29 06:54 ESTNewsAlimera Sciences EPS misses by $0.09, misses on revenueN/A
2021-04-14 21:10 ESTNewsAlimera Sciences receives $20M from Ocumension TherapeuticsN/A
2021-03-17 18:11 ESTNewsAlimera achieves private healthcare reimbursement for Iluvien in IrelandN/A
2021-03-02 11:04 ESTFinancialsCompany financials have been released.Neutral
2021-02-28 23:04 ESTAnalyst RatingThe Analyst Target Price has increased from $13.5 to $14.25.Buy
2021-02-28 01:23 ESTNewsAlimera Sciences, Inc. (ALIM) CEO Rick Eiswirth on Q4 2020 Results - Earnings Call TranscriptN/A
2021-02-27 11:04 ESTFinancialsCompany financials have been released.Neutral
2021-02-25 11:06 ESTEarnings EstimateAn EPS average of $1.80 is estimated for the 2022 year.Buy
2021-02-25 11:06 ESTEarnings EstimateAn EPS average of -$0.19 is estimated for the quarter ending on June 30, 2021.Sell
2021-02-24 21:44 ESTNewsAlimera Sciences EPS misses by $0.16, beats on revenueN/A
2021-01-19 23:49 ESTNewsAlimera Sciences +14%, provides preliminary Q4 and FY numbersN/A
2020-12-19 01:07 ESTNewsEyePoint Pharma reports $16.5M monetization of Iluvien royalty with SWK HoldingsN/A
2020-12-13 03:08 ESTFinancialsCompany financials have been released.Neutral
2020-12-11 15:06 ESTFinancialsCompany financials have been released.Neutral
2020-11-25 11:10 ESTFinancialsCompany financials have been released.Neutral

About Alimera Sciences, Inc (ALIM):

Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of prescription ophthalmic pharmaceuticals in the United States and internationally. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and could lead to severe vision loss and blindness; and to prevent relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye. The company sells its products to physician offices, pharmacies, and hospitals through direct sales and distributors. It has a collaboration agreement with EyePoint Pharmaceuticals US, Inc. for the development and sale of insert technology to deliver other corticosteroids to the back of the eye for the treatment and prevention of eye diseases in humans or to treat diabetic macular edema. The company was incorporated in 2003 and is headquartered in Alpharetta, Georgia.

ALIM Quotes by TradingView

See Advanced Chart

General

  • Name Alimera Sciences, Inc
  • Symbol ALIM
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-Specialty & Generic
  • Full Time Employees 130
  • Last Split Factor1:15
  • Last Split Date2019-11-15
  • Fiscal Year EndDecember
  • IPO Date2010-04-22
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.alimerasciences.com
View More

Valuation

  • Forward PE 60.61
  • Price/Sales (Trailing 12 Mt.) 1.1
  • Enterprise Value Revenue 2.25
  • Enterprise Value EBITDA 43.18
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.12
  • Next Year EPS Estimate $0.81
  • Next Quarter EPS Estimate -$0.08
  • Profit Margin -11%
  • Operating Margin -2%
  • Return on Assets -1%
  • Revenue 50.82 million
  • Earnings Per Share $0.30
  • Revenue Per Share $9.93
  • Gross Profit 43.88 million
  • Quarterly Earnings Growth -20.6%
View More

Highlights

  • Market Capitalization 62.14 million
  • EBITDA 1.78 million
  • Analyst Target Price $14.25
  • Book Value Per Share -$0.48
View More

Share Statistics

  • Shares Outstanding 5.75 million
  • Shares Float 4.5 million
  • % Held by Insiders 1635%
  • % Held by Institutions 40.26%
  • Shares Short 135864
  • Shares Short Prior Month 138171
  • Short Ratio 1.31
  • Short % of Float 3%
  • Short % of Shares Outstanding 2%
View More

Technicals

  • Beta 1.66
  • 52 Week High $11.5
  • 52 Week Low $2.92
  • 50 Day Moving Average 8.56
  • 200 Day Moving Average 5.89
View More

Dividends

  • Dividend Date 2019-11-15
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Alimera Sciences, Inc (ALIM) Dividend Calendar:

ALIM's last dividend payment was made to shareholders on November 15, 2019.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Alimera Sciences, Inc (ALIM) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-24$N/A-$0.21-$0.14-56.15%
2020-09-302020-10-28$N/A-$0.17-$0.2939.1%
2020-06-302020-07-29$N/A-$0.53-$1.2557.78%
2020-03-312020-04-29$N/A-$0.22-$0.4650.7%
2019-12-312020-02-26$17.35 million$0.07-$0.29124.86%
2019-09-302019-10-29$12.85 million-$0.63-$0.55-15.36%
2019-06-302019-07-29$10.86 million-$1.04-$0.50-107.6%
2019-03-312019-04-29$12.89 million-$0.57-$0.639.33%
2018-12-312019-02-19$15.11 million-$0.12-$0.4574%
2018-09-302018-11-06$11.14 million-$0.59-$0.9437.6%
2018-06-302018-07-30$10.92 million-$0.85-$0.9812.77%
2018-03-312018-05-03$9.8 million-$1.20-$0.53-128.57%
2017-12-312018-02-28$9.14 million-$1.57-$0.65-141.62%
2017-09-302017-11-01$9.78 million-$1.78-$0.65-174.15%
2017-06-302017-08-02$10.37 million-$0.64-$0.9532.26%
2017-03-312017-05-08$6.62 million-$1.50-$1.500%
2016-12-312017-03-01$10.68 million-$1.50-$1.35-11.11%
2016-09-302016-11-02$8.3 million-$2.30-$1.65-39.45%
2016-06-302016-08-03$9.56 million-$2.55-$2.48-3.03%
2016-03-312016-05-04$5.8 million-$3.30-$2.85-15.79%
2015-12-312016-03-03$5.82 million-$3.60-$3.50-2.86%
2015-09-302015-11-05$6.9 million-$0.03-$0.2185.71%
2015-06-302015-08-10$5.78 million-$0.19-$0.2213.64%
2015-03-312015-05-07$3.94 million-$0.22-$0.248.33%
2014-12-312015-03-04$1.74 million-$0.23-$0.17-35.29%
2014-09-302014-11-06$2.41 million-$0.17-$0.7075.71%
2014-06-302014-08-07$2.19 million$0.60-$3.37117.8%
2014-03-312014-05-08$2.08 million-$3.00-$3.6718.26%
2013-12-312014-02-27$935000-$6.30-$4.28-47.2%
2013-09-302013-11-11$758000-$3.90-$4.4211.76%
2013-06-302013-08-12$179000-$4.50-$3.60-25%
2013-03-312013-05-09$N/A-$4.05-$3.97-2.02%
2012-12-312013-03-21$N/A-$2.55-$3.4526.09%
2012-09-302012-11-07$N/A-$2.55-$2.705.56%
2012-06-302012-08-09$N/A-$2.25-$2.447.79%
2012-03-312012-05-11$N/A-$2.10-$1.86-12.9%
2011-12-312012-03-08$N/A-$2.85-$3.3414.67%
2011-09-302011-11-03$N/A-$3.15-$2.85-10.53%
2011-06-302011-08-04$N/A-$2.55-$2.9112.37%
2011-03-312011-05-05$N/A-$2.25-$2.9222.95%
2010-12-312011-02-10$N/A-$3.00-$3.3410.18%
2010-09-302010-11-04$N/A-$3.00-$3.9423.86%
2010-06-302010-08-12$N/A-$4.05-$3.94-2.79%
2010-03-312010-06-03$N/A-$65.55-$7.35-791.84%

Alimera Sciences, Inc (ALIM) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Alimera Sciences, Inc (ALIM) Chart:

Alimera Sciences, Inc (ALIM) News:

Below you will find a list of latest news for Alimera Sciences, Inc (ALIM) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Alimera Sciences, Inc (ALIM) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Alimera Sciences, Inc (ALIM) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000100/0001267602-20-000100-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1267602/000090266419001015/0000902664-19-001015-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1267602/000090266420001114/0000902664-20-001114-index.htm
2019-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000090445419000515/0000904454-19-000515-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000090445420000413/0000904454-20-000413-index.htm
2020-09-29SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1267602/000090445420000636/0000904454-20-000636-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1267602/000091957419001731/0000919574-19-001731-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1267602/000091957420001599/0000919574-20-001599-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1267602/000093583619000096/0000935836-19-000096-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1267602/000093583619000107/0000935836-19-000107-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1267602/000093583620000106/0000935836-20-000106-index.htm
2020-08-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1267602/000094280120000005/0000942801-20-000005-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1267602/000110465919008752/0001104659-19-008752-index.htm
2019-11-01SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1267602/000110465919058965/0001104659-19-058965-index.htm
2019-12-11SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1267602/000110465919071699/0001104659-19-071699-index.htm
2020-01-24SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1267602/000110465920006592/0001104659-20-006592-index.htm
2020-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1267602/000110465920016248/0001104659-20-016248-index.htm
2019-02-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1267602/000119312519039128/0001193125-19-039128-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1267602/000119312519041151/0001193125-19-041151-index.htm
2020-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1267602/000119312520030598/0001193125-20-030598-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1267602/000119380519000185/0001193805-19-000185-index.htm
2020-01-23SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1267602/000119380520000056/0001193805-20-000056-index.htm
2019-01-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000026/0001267602-19-000026-index.htm
2019-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000029/0001267602-19-000029-index.htm
2019-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000030/0001267602-19-000030-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000032/0001267602-19-000032-index.htm
2019-02-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000035/0001267602-19-000035-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000037/0001267602-19-000037-index.htm
2019-02-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000039/0001267602-19-000039-index.htm
2019-02-2510-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1267602/000126760219000043/0001267602-19-000043-index.htm
2019-02-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000045/0001267602-19-000045-index.htm
2019-03-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000047/0001267602-19-000047-index.htm
2019-03-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000050/0001267602-19-000050-index.htm
2019-04-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000052/0001267602-19-000052-index.htm
2019-04-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000054/0001267602-19-000054-index.htm
2019-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000058/0001267602-19-000058-index.htm
2019-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000060/0001267602-19-000060-index.htm
2019-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000063/0001267602-19-000063-index.htm
2019-05-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000067/0001267602-19-000067-index.htm
2019-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000070/0001267602-19-000070-index.htm
2019-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000071/0001267602-19-000071-index.htm
2019-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1267602/000126760219000075/0001267602-19-000075-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000077/0001267602-19-000077-index.htm
2019-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000079/0001267602-19-000079-index.htm
2019-06-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000083/0001267602-19-000083-index.htm
2019-06-20S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000085/0001267602-19-000085-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000087/0001267602-19-000087-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000092/0001267602-19-000092-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000093/0001267602-19-000093-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000094/0001267602-19-000094-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000095/0001267602-19-000095-index.htm
2019-07-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000097/0001267602-19-000097-index.htm
2019-07-223Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000099/0001267602-19-000099-index.htm
2019-07-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000101/0001267602-19-000101-index.htm
2019-07-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000103/0001267602-19-000103-index.htm
2019-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1267602/000126760219000106/0001267602-19-000106-index.htm
2019-09-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000109/0001267602-19-000109-index.htm
2019-09-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000111/0001267602-19-000111-index.htm
2019-09-16PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000113/0001267602-19-000113-index.htm
2019-09-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000117/0001267602-19-000117-index.htm
2019-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000122/0001267602-19-000122-index.htm
2019-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000123/0001267602-19-000123-index.htm
2019-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000124/0001267602-19-000124-index.htm
2019-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000125/0001267602-19-000125-index.htm
2019-09-27DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000127/0001267602-19-000127-index.htm
2019-10-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000134/0001267602-19-000134-index.htm
2019-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000136/0001267602-19-000136-index.htm
2019-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000138/0001267602-19-000138-index.htm
2019-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000140/0001267602-19-000140-index.htm
2019-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000142/0001267602-19-000142-index.htm
2019-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000147/0001267602-19-000147-index.htm
2019-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000148/0001267602-19-000148-index.htm
2019-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000149/0001267602-19-000149-index.htm
2019-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000150/0001267602-19-000150-index.htm
2019-10-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000153/0001267602-19-000153-index.htm
2019-10-25424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1267602/000126760219000155/0001267602-19-000155-index.htm
2019-10-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000157/0001267602-19-000157-index.htm
2019-11-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000162/0001267602-19-000162-index.htm
2019-11-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000163/0001267602-19-000163-index.htm
2019-11-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000164/0001267602-19-000164-index.htm
2019-11-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000165/0001267602-19-000165-index.htm
2019-11-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000167/0001267602-19-000167-index.htm
2019-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1267602/000126760219000169/0001267602-19-000169-index.htm
2019-11-078-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000171/0001267602-19-000171-index.htm
2019-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000173/0001267602-19-000173-index.htm
2019-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000175/0001267602-19-000175-index.htm
2019-11-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000178/0001267602-19-000178-index.htm
2019-11-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000180/0001267602-19-000180-index.htm
2019-11-194/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000187/0001267602-19-000187-index.htm
2019-11-194/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000188/0001267602-19-000188-index.htm
2019-11-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000189/0001267602-19-000189-index.htm
2019-11-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000190/0001267602-19-000190-index.htm
2019-11-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000191/0001267602-19-000191-index.htm
2019-11-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000192/0001267602-19-000192-index.htm
2019-11-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000194/0001267602-19-000194-index.htm
2019-11-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000196/0001267602-19-000196-index.htm
2019-12-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000201/0001267602-19-000201-index.htm
2019-12-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000202/0001267602-19-000202-index.htm
2019-12-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000203/0001267602-19-000203-index.htm
2019-12-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000204/0001267602-19-000204-index.htm
2019-12-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000206/0001267602-19-000206-index.htm
2019-12-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000211/0001267602-19-000211-index.htm
2019-12-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000212/0001267602-19-000212-index.htm
2019-12-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000213/0001267602-19-000213-index.htm
2019-12-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760219000214/0001267602-19-000214-index.htm
2020-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000005/0001267602-20-000005-index.htm
2020-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000006/0001267602-20-000006-index.htm
2020-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000007/0001267602-20-000007-index.htm
2020-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000008/0001267602-20-000008-index.htm
2020-01-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000011/0001267602-20-000011-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000017/0001267602-20-000017-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000018/0001267602-20-000018-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000019/0001267602-20-000019-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000020/0001267602-20-000020-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000021/0001267602-20-000021-index.htm
2020-02-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000025/0001267602-20-000025-index.htm
2020-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000027/0001267602-20-000027-index.htm
2020-03-0210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1267602/000126760220000029/0001267602-20-000029-index.htm
2020-03-034/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000033/0001267602-20-000033-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000034/0001267602-20-000034-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000035/0001267602-20-000035-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000037/0001267602-20-000037-index.htm
2020-03-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000039/0001267602-20-000039-index.htm
2020-03-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000041/0001267602-20-000041-index.htm
2020-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000043/0001267602-20-000043-index.htm
2020-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000050/0001267602-20-000050-index.htm
2020-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000051/0001267602-20-000051-index.htm
2020-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000052/0001267602-20-000052-index.htm
2020-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000053/0001267602-20-000053-index.htm
2020-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000054/0001267602-20-000054-index.htm
2020-04-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000056/0001267602-20-000056-index.htm
2020-04-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000058/0001267602-20-000058-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000063/0001267602-20-000063-index.htm
2020-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000064/0001267602-20-000064-index.htm
2020-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000068/0001267602-20-000068-index.htm
2020-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000075/0001267602-20-000075-index.htm
2020-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000076/0001267602-20-000076-index.htm
2020-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000077/0001267602-20-000077-index.htm
2020-05-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000079/0001267602-20-000079-index.htm
2020-05-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1267602/000126760220000083/0001267602-20-000083-index.htm
2020-06-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000085/0001267602-20-000085-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000093/0001267602-20-000093-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000094/0001267602-20-000094-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000095/0001267602-20-000095-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000096/0001267602-20-000096-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000097/0001267602-20-000097-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000100/0001267602-20-000100-index.htm
2020-07-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000102/0001267602-20-000102-index.htm
2020-07-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000107/0001267602-20-000107-index.htm
2020-08-0410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1267602/000126760220000109/0001267602-20-000109-index.htm
2020-10-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000111/0001267602-20-000111-index.htm
2020-11-02S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1267602/000126760220000113/0001267602-20-000113-index.htm
2020-11-03S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1267602/000126760220000116/0001267602-20-000116-index.htm
2020-11-0310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1267602/000126760220000118/0001267602-20-000118-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1267602/000130692319000002/0001306923-19-000002-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1267602/000130692320000006/0001306923-20-000006-index.htm
2019-11-20SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1267602/000138713119008898/0001387131-19-008898-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1267602/000138713120001568/0001387131-20-001568-index.htm
2019-09-174/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000147450619000177/0001474506-19-000177-index.htm
2019-09-174/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000147450619000178/0001474506-19-000178-index.htm
2019-09-174/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000147450619000179/0001474506-19-000179-index.htm
2019-09-174/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000147450619000180/0001474506-19-000180-index.htm
2019-09-174/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000147450619000181/0001474506-19-000181-index.htm
2020-08-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000147450620000239/0001474506-20-000239-index.htm
2020-11-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000147450620000291/0001474506-20-000291-index.htm
2020-11-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000147450620000292/0001474506-20-000292-index.htm
2020-11-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000147450620000293/0001474506-20-000293-index.htm
2020-11-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000147450620000294/0001474506-20-000294-index.htm
2020-11-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000147450620000295/0001474506-20-000295-index.htm
2019-01-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267602/000176200719000005/0001762007-19-000005-index.htm
2020-02-19SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1267602/999999999720000801/9999999997-20-000801-index.htm
2020-01-31SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1267602/999999999720001253/9999999997-20-001253-index.htm

Alimera Sciences, Inc (ALIM) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Alimera Sciences, Inc (ALIM). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1635%
Institutional Ownership: 4026%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-11-21John SnisarenkoDirectorBuy10,000.004.9549,500.0010,000.00https://www.sec.gov/Archives/edgar/data/1267602/000126760219000196/0001267602-19-000196-index.htm
2020-03-18Philip AshmanChief Operating Officer & SVPBuy5,389.0010,641.00https://www.sec.gov/Archives/edgar/data/1267602/000126760220000054/0001267602-20-000054-index.htm
2019-09-13John Philip JonesChief Financial OfficerBuy1,454.000.41596.14107,450.00https://www.sec.gov/Archives/edgar/data/1267602/000126760219000122/0001267602-19-000122-index.htm
2019-09-30John Philip JonesChief Financial OfficerBuy1,046.000.57596.22108,496.00https://www.sec.gov/Archives/edgar/data/1267602/000126760219000136/0001267602-19-000136-index.htm
2019-01-23John Philip JonesChief Financial OfficerBuy79,400.00108,596.00https://www.sec.gov/Archives/edgar/data/1267602/000176200719000005/0001762007-19-000005-index.htm
2019-10-15John Philip JonesChief Financial OfficerBuy1,490.000.40596.00109,986.00https://www.sec.gov/Archives/edgar/data/1267602/000126760219000149/0001267602-19-000149-index.htm
2019-04-30John Philip JonesChief Financial OfficerBuy1,633.000.821,346.41110,229.00https://www.sec.gov/Archives/edgar/data/1267602/000126760219000070/0001267602-19-000070-index.htm
2019-10-31John Philip JonesChief Financial OfficerBuy2,104.000.28596.27112,090.00https://www.sec.gov/Archives/edgar/data/1267602/000126760219000164/0001267602-19-000164-index.htm
2019-10-31John Philip JonesChief Financial OfficerBuy2,500.000.24602.25114,590.00https://www.sec.gov/Archives/edgar/data/1267602/000126760219000164/0001267602-19-000164-index.htm
2020-03-18John Philip JonesChief Financial OfficerBuy3,958.0011,768.00https://www.sec.gov/Archives/edgar/data/1267602/000126760220000053/0001267602-20-000053-index.htm
2020-04-30John Philip JonesChief Financial OfficerBuy167.003.61603.4011,935.00https://www.sec.gov/Archives/edgar/data/1267602/000126760220000075/0001267602-20-000075-index.htm
2020-11-04Philip AshmanChief Operating Officer & SVPBuy1,316.004.505,921.8711,957.00https://www.sec.gov/Archives/edgar/data/1267602/000147450620000295/0001474506-20-000295-index.htm
2020-10-30John Philip JonesChief Financial OfficerBuy421.003.561,499.3912,356.00https://www.sec.gov/Archives/edgar/data/1267602/000147450620000293/0001474506-20-000293-index.htm
2019-11-01John Philip JonesChief Financial OfficerBuy10,000.000.303,008.00124,590.00https://www.sec.gov/Archives/edgar/data/1267602/000126760219000164/0001267602-19-000164-index.htm
2019-11-15David HollandChief Marketing Officer & SVPBuy170.004.75807.5017,795.00https://www.sec.gov/Archives/edgar/data/1267602/000126760219000191/0001267602-19-000191-index.htm
2019-11-29David HollandChief Marketing Officer & SVPBuy142.005.66803.7217,937.00https://www.sec.gov/Archives/edgar/data/1267602/000126760219000203/0001267602-19-000203-index.htm
2019-12-13David HollandChief Marketing Officer & SVPBuy98.008.24807.5218,035.00https://www.sec.gov/Archives/edgar/data/1267602/000126760219000213/0001267602-19-000213-index.htm
2019-12-31David HollandChief Marketing Officer & SVPBuy106.007.58803.4818,141.00https://www.sec.gov/Archives/edgar/data/1267602/000126760220000005/0001267602-20-000005-index.htm
2020-03-18David HollandChief Marketing Officer & SVPBuy5,172.0020,773.00https://www.sec.gov/Archives/edgar/data/1267602/000126760220000051/0001267602-20-000051-index.htm
2020-04-30David HollandChief Marketing Officer & SVPBuy167.003.61603.4020,940.00https://www.sec.gov/Archives/edgar/data/1267602/000126760220000077/0001267602-20-000077-index.htm
2020-10-30David HollandChief Marketing Officer & SVPBuy500.003.561,780.7521,440.00https://www.sec.gov/Archives/edgar/data/1267602/000147450620000292/0001474506-20-000292-index.htm
2019-09-13David HollandChief Marketing Officer & SVPBuy1,970.000.41807.70255,592.00https://www.sec.gov/Archives/edgar/data/1267602/000126760219000124/0001267602-19-000124-index.htm
2019-09-30David HollandChief Marketing Officer & SVPBuy1,417.000.57807.69257,009.00https://www.sec.gov/Archives/edgar/data/1267602/000126760219000142/0001267602-19-000142-index.htm
2019-10-15David HollandChief Marketing Officer & SVPBuy2,020.000.40808.00259,029.00https://www.sec.gov/Archives/edgar/data/1267602/000126760219000150/0001267602-19-000150-index.htm
2019-10-31David HollandChief Marketing Officer & SVPBuy2,850.000.28807.69261,879.00https://www.sec.gov/Archives/edgar/data/1267602/000126760219000163/0001267602-19-000163-index.htm
2019-10-31David HollandChief Marketing Officer & SVPBuy2,500.000.24602.25264,379.00https://www.sec.gov/Archives/edgar/data/1267602/000126760219000163/0001267602-19-000163-index.htm
2019-11-19James R LargentDirectorBuy3,000.005.1115,344.103,000.00https://www.sec.gov/Archives/edgar/data/1267602/000126760219000194/0001267602-19-000194-index.htm
2019-11-15RICHARD S JR EISWIRTHPresident and CEOBuy323.004.751,534.2531,249.00https://www.sec.gov/Archives/edgar/data/1267602/000126760219000189/0001267602-19-000189-index.htm
2019-11-29RICHARD S JR EISWIRTHPresident and CEOBuy271.005.661,533.8631,520.00https://www.sec.gov/Archives/edgar/data/1267602/000126760219000204/0001267602-19-000204-index.htm
2019-12-13RICHARD S JR EISWIRTHPresident and CEOBuy186.008.241,532.6431,706.00https://www.sec.gov/Archives/edgar/data/1267602/000126760219000211/0001267602-19-000211-index.htm
2019-12-31RICHARD S JR EISWIRTHPresident and CEOBuy202.007.581,531.1631,908.00https://www.sec.gov/Archives/edgar/data/1267602/000126760220000007/0001267602-20-000007-index.htm
2019-04-30RICHARD S JR EISWIRTHPresident and CEOBuy2,500.000.822,061.25345,704.00https://www.sec.gov/Archives/edgar/data/1267602/000126760219000071/0001267602-19-000071-index.htm
2019-09-13RICHARD S JR EISWIRTHPresident and CEOBuy3,745.000.411,535.45349,449.00https://www.sec.gov/Archives/edgar/data/1267602/000126760219000123/0001267602-19-000123-index.htm
2019-09-30RICHARD S JR EISWIRTHPresident and CEOBuy2,694.000.571,535.58352,143.00https://www.sec.gov/Archives/edgar/data/1267602/000126760219000138/0001267602-19-000138-index.htm
2019-10-15RICHARD S JR EISWIRTHPresident and CEOBuy3,839.000.401,535.60355,982.00https://www.sec.gov/Archives/edgar/data/1267602/000126760219000148/0001267602-19-000148-index.htm
2019-10-31RICHARD S JR EISWIRTHPresident and CEOBuy5,419.000.281,535.74361,401.00https://www.sec.gov/Archives/edgar/data/1267602/000126760219000162/0001267602-19-000162-index.htm
2019-10-31RICHARD S JR EISWIRTHPresident and CEOBuy2,500.000.24602.25363,901.00https://www.sec.gov/Archives/edgar/data/1267602/000126760219000162/0001267602-19-000162-index.htm
2020-03-18RICHARD S JR EISWIRTHPresident and CEOBuy10,884.0038,876.00https://www.sec.gov/Archives/edgar/data/1267602/000126760220000052/0001267602-20-000052-index.htm
2020-04-30RICHARD S JR EISWIRTHPresident and CEOBuy167.003.61603.4039,043.00https://www.sec.gov/Archives/edgar/data/1267602/000126760220000076/0001267602-20-000076-index.htm
2020-10-30RICHARD S JR EISWIRTHPresident and CEOBuy500.003.561,780.7539,543.00https://www.sec.gov/Archives/edgar/data/1267602/000147450620000291/0001474506-20-000291-index.htm
2020-11-02RICHARD S JR EISWIRTHPresident and CEOBuy2,500.004.1510,377.0042,043.00https://www.sec.gov/Archives/edgar/data/1267602/000147450620000294/0001474506-20-000294-index.htm
2019-11-14RICHARD S JR EISWIRTHPresident and CEOBuy75,000.000.3022,417.50438,901.00https://www.sec.gov/Archives/edgar/data/1267602/000126760219000180/0001267602-19-000180-index.htm
2019-11-14RICHARD S JR EISWIRTHPresident and CEOBuy25,000.000.307,472.50463,901.00https://www.sec.gov/Archives/edgar/data/1267602/000126760219000180/0001267602-19-000180-index.htm
2019-11-15Samer KabaChief Medical OfficerBuy149.004.75707.755,367.00https://www.sec.gov/Archives/edgar/data/1267602/000126760219000192/0001267602-19-000192-index.htm
2019-11-29Samer KabaChief Medical OfficerBuy126.005.66713.165,493.00https://www.sec.gov/Archives/edgar/data/1267602/000126760219000202/0001267602-19-000202-index.htm
2020-08-20C. Daniel MyersDirectorSell5,000.006.7333,650.005,578.00https://www.sec.gov/Archives/edgar/data/1267602/000147450620000239/0001474506-20-000239-index.htm
2019-12-13Samer KabaChief Medical OfficerBuy86.008.24708.645,579.00https://www.sec.gov/Archives/edgar/data/1267602/000126760219000212/0001267602-19-000212-index.htm
2019-12-31Samer KabaChief Medical OfficerBuy93.007.58704.945,672.00https://www.sec.gov/Archives/edgar/data/1267602/000126760220000006/0001267602-20-000006-index.htm
2019-09-13Samer KabaChief Medical OfficerBuy1,736.000.41711.7672,736.00https://www.sec.gov/Archives/edgar/data/1267602/000126760219000125/0001267602-19-000125-index.htm
2019-09-30Samer KabaChief Medical OfficerBuy1,249.000.57711.9373,985.00https://www.sec.gov/Archives/edgar/data/1267602/000126760219000140/0001267602-19-000140-index.htm
2019-10-15Samer KabaChief Medical OfficerBuy1,779.000.40711.6075,764.00https://www.sec.gov/Archives/edgar/data/1267602/000126760219000147/0001267602-19-000147-index.htm
2019-10-31Samer KabaChief Medical OfficerBuy2,513.000.28712.1878,277.00https://www.sec.gov/Archives/edgar/data/1267602/000126760219000165/0001267602-19-000165-index.htm
2019-11-15John Philip JonesChief Financial OfficerBuy125.004.75593.758,431.00https://www.sec.gov/Archives/edgar/data/1267602/000126760219000190/0001267602-19-000190-index.htm
2019-11-29John Philip JonesChief Financial OfficerBuy105.005.66594.308,536.00https://www.sec.gov/Archives/edgar/data/1267602/000126760219000201/0001267602-19-000201-index.htm
2020-03-18Samer KabaChief Medical OfficerBuy4,683.008,679.00https://www.sec.gov/Archives/edgar/data/1267602/000126760220000050/0001267602-20-000050-index.htm
2019-12-10John Philip JonesChief Financial OfficerBuy1,000.009.299,293.709,536.00https://www.sec.gov/Archives/edgar/data/1267602/000126760219000206/0001267602-19-000206-index.htm
2019-12-13John Philip JonesChief Financial OfficerBuy72.008.24593.289,608.00https://www.sec.gov/Archives/edgar/data/1267602/000126760219000214/0001267602-19-000214-index.htm
2019-12-31John Philip JonesChief Financial OfficerBuy78.007.58591.249,686.00https://www.sec.gov/Archives/edgar/data/1267602/000126760220000008/0001267602-20-000008-index.htm